Susquehanna International Group
ELOS

Susquehanna International Group’s Syneron Medical Ltd ELOS Stock Holding History

Susquehanna International Group’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,350
Closed -$168K – 10327
2017
Q1 		$162K Buy
+15,350
New +$148K ﹤0.01% 8152
2014
Q1 		– Sell
-32,994
Closed -$406K – 9738
2013
Q4 		$406K Buy
+32,994
New +$343K ﹤0.01% 7086

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Susquehanna International Group's ELOS Position: Q2 2017 in Review

Susquehanna International Group sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 15,350 shares — an estimated $168K sold.

Susquehanna International Group first reported a position in ELOS in Q4 2013 and held it in 2 quarters. The position peaked at $406K in Q4 2013. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Susquehanna International Group reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Susquehanna International Group sold 15,350 Syneron Medical Ltd shares in Q2 2017, an estimated $168K.
  • Susquehanna International Group first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 2 quarters.
  • Susquehanna International Group's Syneron Medical Ltd position peaked at $406K in Q4 2013.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.